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A Quantitative Release Assessment for the Noncommercial
Movement of Companion Animals: Risk of Rabies
Reintroduction to the United Kingdom
A. D. Goddard,1,∗ N. M. Donaldson,1 D. L. Horton,2 R. Kosmider,1 L. A. Kelly,1,3
A. R. Sayers,1 A. C. Breed,1 C. M. Freuling,4 T. Mu¨ller,4 S. E. Shaw,5 G. Hallgren,6
A. R. Fooks,2,7 and E. L. Snary1
In 2004, the European Union (EU) implemented a pet movement policy (referred to here
as the EUPMP) under EU regulation 998/2003. The United Kingdom (UK) was granted a
temporary derogation from the policy until December 2011 and instead has in place its own
Pet Movement Policy (Pet Travel Scheme (PETS)). A quantitative risk assessment (QRA)
was developed to estimate the risk of rabies introduction to the UK under both schemes to
quantify any change in the risk of rabies introduction should the UK harmonize with the
EU policy. Assuming 100% compliance with the regulations, moving to the EUPMP was
predicted to increase the annual risk of rabies introduction to the UK by approximately 60-
fold, from 7.79 × 10−5 (5.90 × 10−5, 1.06 × 10−4) under the current scheme to 4.79 × 10−3
(4.05 × 10−3, 5.65 × 10−3) under the EUPMP. This corresponds to a decrease from 13,272
(9,408, 16,940) to 211 (177, 247) years between rabies introductions. The risks associated with
both the schemes were predicted to increase when less than 100% compliance was assumed,
with the current scheme of PETS and quarantine being shown to be particularly sensitive to
noncompliance. The results of this risk assessment, along with other evidence, formed a sci-
entific evidence base to inform policy decision with respect to companion animal movement.
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1. INTRODUCTION
Rabies is a zoonotic viral disease that causes
acute encephalitis in humans and other warm-
blooded animals; the clinical disease is untreatable
and almost always fatal. Transmission occurs usu-
ally through saliva via the bite of an infected ani-
mal, with dogs being the main transmitter of rabies
virus to humans. The United Kingdom (UK) is of-
ficially classified as being free from terrestrial ra-
bies;(1,2) the last case of indigenous terrestrial animal
rabies was in 1922. This rabies-free status was histor-
ically achieved by the investigation of every case of
suspected disease and strict controls on dog and cat
movements, and thenmaintained by the enforcement
of a six-month quarantine period for all animals en-
tering from abroad.
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Table I. A Comparison of the Requirements of the Various Pet Movement Policies Considered in this Risk Assessment; Six-Month
Quarantine in the United Kingdom (UK), the UK Pet Travel Scheme (PETS), and the European Union Pet Movement Policy (EUPMP)
for EU Members States and Listed Countries (EUPMPEU&listed) and Unlisted Countries (EUPMPunlisted)
Movement Policy
Requirement Quarantine PETS EUPMPEU&listed EUPMPunlisted
Microchip No Yes Yes Yes
Vaccination Yes (once in UK) Yes Yes Yes
Blood sample No Yes No Yes
Waiting period 6 months (in UK quarantine) 6 months 21 days 3 months
The current UK scheme for the movement of
companion animals (dogs, cats, and ferrets), the Pet
Travel Scheme (PETS), has been in place since 2000.
This scheme allows companion animals from Euro-
pean Union (EU) Member States (MSs) and equiv-
alents, and listed third countries, to enter the UK
via a process involving microchipping for identifica-
tion, vaccination against rabies, and serological test-
ing for rabies-specific antibodies. After successful
testing the animal must complete a six-month wait-
ing period and receive tick and tapeworm treatment
24–48 hours before entry into the UK.(3) Companion
animal entries from countries that do not qualify for
PETS must complete six months in quarantine at a
UK quarantine center, during which time the animal
is vaccinated against rabies. Before 2000, all compan-
ion animal entries to the UK were subject to this six-
month quarantine. During 2010, 82,512 dogs, 7,870
cats, and 64 ferrets entered the UK through PETS. In
total, 752,945 animals, including those returning from
trips abroad, have entered the UK under this scheme
since 2000, and there have been no cases of rabies in
any of these animals.
Comprehensive vaccination campaigns in foxes
have helped to eliminate sylvatic rabies in many EU
MSs; however, there is a constant threat of rein-
troduction through the importation of animals incu-
bating the disease, especially from rabies endemic
countries, considering the increasing trend in the
noncommercial movement of animals around the
world. Hence MSs need to maintain vigilance us-
ing appropriate control measures.(4) In 2004, the EU
implemented a harmonized pet movement policy
(referred to here as the EUPMP) under EU reg-
ulation 998/2003. The UK (and a number of other
EU MSs) was granted derogation from this policy,
initially due to expire in July 2008, but later ex-
tended until December 2011. Under the EUPMP,
companion animals can move between EU MSs and
into the EU from listed third countries providing
they have been identified (either by tattoo or mi-
crochip), vaccinated against rabies, and have com-
pleted a 21-day waiting period before movement
between countries (EUPMPEU&listed). Companion
animals from unlisted third countries must be identi-
fied, vaccinated, serologically tested, and must com-
plete a three-month waiting period in the coun-
try of origin after testing before entry into an EU
MS (EUPMPunlisted). A comparison of the various
schemes is given in Table I.
If the UK’s derogation from the EUPMP were
to expire in December 2011, PETS and quaran-
tine could be replaced by EUPMPEU&listed and
EUPMPunlisted, respectively.(5) It was therefore con-
sidered prudent to assess the impact of this potential
change in policy on the risk of rabies entering the UK
due to the movement of companion animals so that
an evidence base can be collected to help inform gov-
ernment policy decisions. To this effect, a quantita-
tive risk assessment (QRA) model was developed to
address the following risk questions: (i) How would
the risk of rabies introduction to the UK via trav-
eling companion animals change if the UK were to
apply the current harmonized EU rules for the non-
commercial movement of pets? (ii) How would the
risk of rabies introduction from all countries change
when rules are followed with 100% compliance or
with varying degrees of less than 100% compliance?
The resulting QRA developed was based on previous
models constructed for companion animal entries
from North America and Turkey;(6,7) however, the
methodologies were substantially extended to con-
sider entries from all countries. The outputs from the
model are the annual probability of at least one com-
panion animal that is incubating rabies virus entering
the UK and the number of years between rabies in-
troductions to the UK. Ferrets are not included in the
model as (compared to dogs and cats) only a small
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Fig. 1. The pathway used to model the risk of rabies introduction to the United Kingdom (UK) through six months in UK quarantine.
number enter the UK each year and there are very
few data available relating specifically to rabies in
ferrets.
2. MATERIALS ANDMETHODS
2.1. Risk Pathways
A risk pathway is required to identify the biolog-
ical sequence of events that must take place in or-
der for the hazard (i.e., rabies) being modeled to oc-
cur; in this case, the risk of at least one cat/dog in-
cubating rabies virus entering the UK. The pathways
for rabies importation to the UK used in this QRA,
adopted from those in Ramnial et al.,(7) are given in
Figs. 1–3. These pathways assume that animals that
are infected with rabies virus, but yet to show clini-
cal signs, are the only source of rabies introduction
to the UK. Any animals displaying clinical signs of
rabies before entry would be detected and removed
from the scheme.
2.2. Country Groupings
The QRA is on a worldwide scale (i.e., not just
restricted to a few countries/regions). Under PETS
(and the EUPMP) all countries are assigned (ac-
cording to EU regulation 998/2003) to one of three
categories: EU MSs (and equivalents), listed third
countries, and unlisted third countries. However, it
is recognized that there is significant variability be-
tween countries within these categories in relation to
the prevalence/incidence of rabies in their dog, cat,
and wildlife populations. Therefore, countries were
grouped within these three categories according to
their annual number of reported rabies cases, thus
overcoming the need to model each country individ-
ually. This also allowed for consideration of those
countries for which these data on rabies cases and/or
the animal population were either incomplete or ab-
sent. The concept of grouping countries has been
used in many previous rabies risk assessments.(8,9)
To aid in grouping the countries, quantitative
data on the number of reported rabies cases in
dogs and cats in each country were assimilated from
a number of sources.(10−12) Where possible, rabies
cases in wild animals were kept separate from those
in domestic dogs and cats to derive the most accu-
rate number of rabies cases in animals that would
be likely to travel internationally. Data were col-
lected for the three-year period, 2007–2009, to collate
the most recent data reporting rabies cases includ-
ing the year-to-year variation. The individual coun-
tries within each of the three categories (EU MSs,
listed third countries, and unlisted third countries)
were collected into three groups, giving nine groups
in total. The three within category risk groups were
defined as follows: Group 1, no reported cases of
rabies in cats, dogs, and wildlife during 2007–2009;
Group 2, less than or equal to five total cases re-
ported in cats and dogs during 2007–2009 and/or ra-
bies present in wildlife; Group 3, greater than five
cases reported in cats and dogs during 2007–2009.
It was considered particularly important that coun-
tries with rabies in their wildlife population (not in-
cluding lyssavirus species 2–11 in bats), but with no
or very few cat/dog cases (from spill over events),
be separated from those countries with no reports
of rabies and those with a high number of rabies
cases in domestic animals, hence the inclusion of
Group 2. After collection of the incidence data and
discussion with relevant experts, the threshold of five
cases was selected as an appropriate value to use
to differentiate between these two country groups.
Countries for which quantitative data on rabies cases
were incomplete or unavailable were assigned to
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Fig. 2. The pathway used to model the risk of rabies introduction to the United Kingdom through the Pet Travel Scheme (PETS) and the
European Union Pet Movement Policy for unlisted countries (EUPMPunlisted). Illegal pathways are highlighted in italics.
Groups 1–3 according to their classification of “No
Risk,” “Low Risk,” or “High Risk” in a Health Pro-
tection Agency (HPA) assessment of the rabies risk
to UK travelers,(13) which is based on rabies cases
in all terrestrial animals. For countries where data
are available, the HPA distinction between “Low
Risk” and “High Risk” is broadly in agreement with
our cut-off value of five cases between Group 2 and
Group 3.
2.3. Parameter Estimation
The probabilities in Figs. 1–3 were estimated us-
ing data from published and unpublished research,
government databases, and, where necessary, expert
opinion. Many of the parameters in the pathways are
specific to each country group. Where appropriate,
the subscript j, j = 1 . . . 9, was used to represent these
groups: EU MSs (j = 1, 2, 3), listed countries (j =
4, 5, 6), and unlisted third countries (j = 7, 8, 9).
The parameter values are presented with associated
uncertainty; variability was not considered in the
model.
2.3.1. Incubation Period of Rabies (IP)
The incubation period of rabies virus can be esti-
mated from data on experimentally infected and/or
naturally infected cases of rabies;(8,14−22) however,
there is a large amount of uncertainty associated with
both types of data (e.g., unknown date of infection
in natural cases and potentially different incubation
Risk of Rabies Reintroduction to the United Kingdom 1773
Fig. 3. The pathway used to model the risk of rabies introduction to the United Kingdom through the European Union Pet Movement
Policy for EU and listed countries (EUPMPEU&listed). Illegal pathways are highlighted in italics.
periods in experimentally infected animals depend-
ing on the dose and route of infection). Therefore,
similar to previous risk assessments(6,7) all available
data sets were grouped and a lognormal distribution
was fitted to the data; newly available data were in-
corporated to improve the estimate given in Jones
et al.(6) This new lognormal distribution has a mean
of 35 days and standard deviation of 36.8 days.
2.3.2. Probability Companion Animal from Country
Group j is Infected (PI,j)
For each country group j, j = 1 . . . 9, the prob-
ability of a companion animal being infected with
rabies was estimated by considering the maximum
number of rabies cases and the cat and dog popula-
tion of countries for which both of these data were
available. For each country within group j, j = 1 . . . 9,
the maximum number of rabies cases over the period
2007–2009 was used to represent the current worse-
case scenario, assuming no underreporting of rabies.
These values were summed to give the maximum
yearly number of rabies cases in each country group
(Ij, j= 1 . . . 9; see Table II). The maximum number of
unobserved rabies cases in a country group (αj) was
calculated as:(7)
α j = IP365 × Ij ,
where IP is the mean incubation period (35 days).
It was assumed that new cases of rabies in a coun-
try group j follow a Poisson process with rate λj.(6)
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Table II. The Maximum Yearly Number of Rabies Cases in
Each Country Grouping Used in the Risk Assessment (Ij);(10−12)
Group 1, No Reported Cases of Rabies in Cats, Dogs, and
Wildlife During 2007–2009; Group 2, Less than or Equal to Five
Total Cases Reported in Cats and Dogs During 2007–2009 and/or
Rabies Present in Wildlife; Group 3, Greater than Five Cases
Reported in Cats and Dogs During 2007–2009
European Union Listed Third Unlisted Third
Member States Countries Countries
(j = 1–3) (j = 4–6) (j = 7–9)
Group 1 0 0 0
Group 2 11 2 0a
Group 3 283 1,689 6,765
aFew data were available on rabies cases in unlisted third coun-
tries; however, a number of countries were placed in Group 2 due
to their “Low Risk” classification in a Health Protection Agency
risk assessment.
Using Bayesian inference, the uncertainty associated
with λj was derived by assuming an uninformed “flat”
prior(23) and a Poisson likelihood. The resulting pos-
terior distribution for λj describes the uncertainty as-
sociated with the number of unobserved cases. This
posterior distribution is given by:
λ j ∼ Gamma(α j + 1, 1).
The probability that a dog/cat from country
group j is infected (PI,j) was then estimated by di-
viding λj by the total cat and dog population of the
countries in that group for which data on both the
number of rabies cases and the dog and cat pop-
ulation (obtained from the World Society for the
Protection of Animals (WSPA) and WAHID) were
available. It was assumed that the estimate (and un-
certainty distribution) for each grouping is represen-
tative of countries within the group for which data
on the number of rabies cases and/or the companion
animal population were unavailable.
2.3.3. Probability that a Vaccinated Pet is not
Protected (PNP)
For this parameter the current OIE guidelines
were used, which dictate that if an animal has a neu-
tralizing antibody titer ≥0.5 international units (IU)
per mL then it is considered to be protected, other-
wise it is unprotected. Data were available on the ef-
ficacy of three rabies vaccines (Rabisin (Rb), Merial,
France; Madivak (Md), Hoechst, Germany; Nobivak
(Nb), Intervet, UK) from a number of experimental
studies on the serological response of dogs and cats
after vaccination,(24−27) see Table III. For each study
and vaccine, the results were corrected to account for
a serological test specificity of <100%, using a neg-
ative binomial distribution to estimate the number
of false-positive animals,(28) thus giving the number
of animals that were truly protected (NV+,m) in each
study (m):
NV+,m = sV,m − NegBin(sV,m + 1, Spm),
where sV,m is the number of animals achieving the
threshold titer and Spm is the specificity of the sero-
logical test used in study m. Data on the vaccine Ra-
bisin were available from four studies; therefore, the
probability of protection after vaccination with Ra-
bisin (PRa+) was estimated by combining these data
using Bayesian inference with an uninformed prior
Beta(1,1) giving:
PRa+ =
Beta
(
4∑
m=1
nRa+,m + 1,
4∑
m=1
NRa,m −
4∑
m=1
nRa+,m + 1
)
,
where NRa,m is the number of animals vaccinated
with Rabisin in study m and nRa+,m is the number
of animals that are truly protected after vaccination
with Rabisin in studym. Only one data set was avail-
able for both Madivak and Nobivak; therefore, the
Table III. Data used to Estimate the Probability of an Animal Not Being Protected from Rabies Infection After Being Administered a
Rabies Vaccine (PNP)
Days Between Number of Number Achieving
Study Vaccine Vaccination Animals Tested Serological Threshold Titer of
Number (m) Reference Used (V) and Testing (NV,m) Test Used >0.5 IU/mL (sV,m)
1 Sihvonen et al. (1995) Rabisin 30–40 83 RFFIT 80
Madivak 47 46
2 Kallel et al. (2006) Rabisin 30 5 RFFIT 4
3 Bahloul et al. (2006) Rabisin 35 4 RFFIT 4
4 Minke et al. (2009) Rabisin 28 15 FAVN 14
Nobivak 15 10
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probability of protection after vaccination with these
vaccines was estimated by:
PV+ = Beta(nV+ + 1, NV − nV+ + 1),
where V = Md, Nb. Limited information is available
on the frequency of use of each vaccine, especially in
countries outside the UK; therefore, assuming each
vaccine is used with the same frequency, the prob-
ability of a cat/dog not being protected (PNP) after
vaccination was estimated from the available data on
all three vaccines, giving an average probability that
a rabies vaccine will not induce protection:
PNP = 1 − PRb+ + PMd+ + PNb+3 .
The mean value for this parameter was 0.186;
however, this value only applies to animals not incu-
bating rabies. For animals that are incubating rabies
virus or have not been vaccinated, PNP is assumed to
equal 1.
2.3.4. Probability that an Unprotected Animal Passes
the Serological Test (PST+)
Companion animals intending to enter the UK
via PETS or EUPMPunlisted should only be allowed
to proceed through the scheme if they are protected
from rabies infection (i.e., have an antibody titer
≥0.5 IU/mL). Unprotected animals should not pass
this test. However, it is unlikely that any test will
be 100% specific; therefore, a small proportion of
unprotected animals may pass the test and be al-
lowed to proceed through the scheme. The average
specificity of the serological tests for rabies antibod-
ies was estimated from published data comparing the
Fluorescent Antibody Virus Neutralization (FAVN)
test and the Rapid Fluorescent Focus Inhibition Test
(RFFIT).(29) A Bayesian model(30) was fitted to the
FAVN data using WinBUGS 1.4 software, assum-
ing that the antibody prevalence in vaccinated dogs
would be high, and low in unvaccinated dogs. Unin-
formative Beta(1,1) priors were used for the FAVN
specificity and sensitivity. A similar model was fit-
ted to the RFFIT data; however, for the sensitivity
and specificity of the FAVN test and the antibody
prevalences, the prior Beta distributions were based
on the parameter estimates from the FAVN model.
The results from these models were used to de-
fine Beta distributions for the FAVN (SpFAVN) and
RFFIT (SpRFFIT) specificities. Given the limited in-
formation on the frequency of use of each test these
values were equally weighted to produce an aver-
age specificity of the serological tests for rabies an-
tibodies (Sp), a mean value of 0.968 in the model.
The probability of an unprotected animal passing the
serological test (PST+) is thus:
PST+ = 1 − Sp.
The serological test results were not corrected
for a sensitivity of <100%; protected animals that
test negative for rabies-virus-specific antibodies will
either be revaccinated and retested or removed from
the scheme; therefore, these animals do not influence
the risk of rabies introduction to the UK.
2.3.5. Probability that an Unprotected Animal
Becomes Infected During Waiting Period
(PI∗,j)
Companion animals that are not protected after
vaccination, or those that have not been vaccinated,
may become infected during the waiting period. This
probability was estimated as:
PI∗, j = 1 − (1 − PI ′, j )T,
where PI’,j is the daily probability of a compan-
ion animal in group j becoming infected and T
is the total waiting period for each scheme (212
days for PETS, 121 days for EUPMPunlisted, and
21 days for EUPMPEU&listed; a one-month wait is as-
sumed between vaccination and testing in PETS and
EUPMPunlisted). The probability of an animal becom-
ing infected while in UK quarantine was not consid-
ered.
The estimate of PI’,j was based on the maximum
annual number of rabies cases in companion animals
between 2007 and 2009 (Ij). Firstly, as for λj, the un-
certainty associated with this number of cases (θ j)
was estimated as:
θ j ∼ Gamma(Ij + 1, 1).
PI’,j was then estimated as:
PI ′, j = θ jN∗j 365
,
where Nj is the combined cat/dog population of
group j. Noncompliant animals are assumed to be
moved into the UK with false documentation after
one day; therefore, in these situations PI∗ ,j = PI’,j.
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2.3.6. Probability that an Infected Animal is
Asymptomatic During the Waiting Period
(PNCS)
It was assumed that companion animals display-
ing clinical signs of rabies would not be allowed to
enter the UK. However, animals that are incubat-
ing the disease and do not show clinical signs dur-
ing the waiting period may enter the country. This
probability is dependent on the time between infec-
tion and entry (t) and the incubation period (IP).
For animals infected before vaccination, the time be-
tween infection and entry is dependent on the wait-
ing period (T) of the entry scheme, assuming that the
animal was infected immediately before vaccination
and enters the country immediately after the wait-
ing period. The probability of the incubation period
being greater than the waiting period in a particular
entry scheme (PNCS) was calculated from the cumu-
lative density function of the lognormal distribution
describing the incubation period:
PNCS = P(IP > T),
where T is the total waiting period as described pre-
viously.
For unprotected animals that become infected
during the waiting period, infection could occur on
any day between the day of vaccination (t = 1) and
the day of entry (t = T). The probability of an ani-
mal that becomes infected during the waiting period
not displaying clinical signs during the waiting period
was calculated by averaging the associated probabil-
ities for each possible day of infection, that is,
PNCS =
T∑
t=1
P(IP > t)
T
.
2.3.7. Probability an Animal Passes Import Checks
from a Country Group j (PC+,j)
Upon arrival at a UK border, a companion ani-
mal may be denied entry if the accompanying paper-
work is unsatisfactory. Data on the number of com-
panion animals presented for entry to the UK (NC,j)
and the number that were subsequently allowed to
enter (nC+,j) were collated from pet travel records in
the UK; see Table IV. For each country group (j =
1, . . . ,6) entering via PETS, the probability of an an-
imal from that group passing documentation checks
upon entry to the UK was therefore estimated as:
PC+, j = Beta(nC+, j + 1, NC, j − nC+, j + 1).
Table IV. The Number of Companion Animals Passing Entry
Checks into the United Kingdom Between 2005 and 2009(33)
Number
Number Passing
Country Country Presented Checks
Classification Group (NC,j) (NC+,j)
EU Member States Group 1 63,863 59,877
and equivalents Group 2 91,056 85,662
Group 3 7,652 6,157
Listed third countries Group 1 7,280 7,184
Group 2 2,206 2,150
Group 3 19,442 17,631
Data are not available for the number of en-
tries from unlisted third countries failing UK entry
checks, as these entries currently go through six-
month quarantine. Therefore, for these countries un-
der the EUPMP, the probability of passing import
checks was estimated using a Beta distribution incor-
porating all the data on animals passing and failing
checks upon entry into the UK.
2.3.8. Compliance Parameters
Noncompliance with the regulations was mod-
eled at the vaccination, testing, and checking stages
of the pathways (see Figs. 2 and 3) by altering the
probabilities of an animal being vaccinated, serolog-
ically tested, and checked, parameters PV, PST, and
PC, respectively. In the baseline model, 100% com-
pliance was assumed; therefore, PV = 1 and PST = 1.
In PETS, all companion animal entries must be
checked; therefore, in this case PC = 1. Under the
EUPMP, entries into the EUmust be checked; there-
fore, PC = 1 for entries from unlisted third countries
in EUPMPunlisted and entries from listed third coun-
tries in EUPMPEU&listed. There is not any require-
ment for checking the movements of companion an-
imal movements between EU MSs in the EUPMP;
therefore, in these cases PC = 0.
The effect of noncompliance with the regulations
on the risk of rabies introduction to the UK was
tested in a scenario analysis where the compliance
parameters were reduced, in a stepwise manner, to
0.9 (90% compliance) and then to 0.8 (80% compli-
ance). This reduction in compliance did not affect
the parameter PV in UK quarantine, where it was as-
sumed that all regulations were complied with, or PC
in movements between MSs in the EUPMP, which
remains at 0 in the compliance analysis. For animals
that were either not vaccinated or not tested, it was
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Table V. The Maximum Annual Number of Companion Animal Entries to the United Kingdom via the Pet Travel Scheme (PETS) and
Quarantine (NI ,j) Between 2005 and 2009(33)
European Union Member States Listed Third
Unlisted Third
Country Group PETS (%) Quarantine (%) PETS (%) Quarantine (%) Quarantine (%)
Group 1 13, 434(97%) 423(3%) 2, 657(92%) 217(8%) 22(100%)
Group 2 19, 830(98%) 403(2%) 859(88%) 121(12%) 51(100%)
Group 3 1, 740(97%) 52(3%) 5, 091(86%) 819(14%) 1, 222(100%)
assumed that they will attempt to enter the UK im-
mediately with false documentation (T = 1 for these
entries). In addition, it was assumed that those an-
imals that had not been vaccinated and will not be
tested for rabies antibodies; therefore, PST = 0 in
these scenarios.
2.3.9. Companion Animal Entries to the UK
The annual number of companion animal en-
tries to the UK from each of the nine country groups
was obtained from pet travel records (Table V). The
maximum number of entries over the last five years
was selected to model a worse-case scenario for com-
panion animal entries, and therefore rabies intro-
duction. It was noted that during this time frame a
substantial number of animals entered the UK from
PETS qualifying countries via quarantine. It is specu-
lated that these may be cats/dogs whose owners have,
for whatever reason, decided to forgo PETS (likely
to be those not wishing to wait for six months be-
fore entering the UK) or cats/dogs that have been
placed in quarantine because they have failed the re-
quirements for PETS. When modeling the current
UK scheme, these animals were assumed to enter
through a full six-month quarantine period; early re-
lease cases were not included in the model. For the
EUPMP, entries through quarantine from qualify-
ing countries (EU and listed) were grouped with the
number of entries through PETS to give an overall
annual number of entries; all of these were assumed
to enter through EUPMPEU&listed. This assumption
was made because under the EUPMP there is likely
to be no option for quarantine, and it was consid-
ered more likely that owners will be willing to wait
21 days before entry. For both schemes, it is assumed
that all animals are entering the UK for the first time
and all animals have fulfilled the requirements and
completed the full waiting period immediately before
entry.
In this QRA, the risk of rabies introduction from
UK animals returning from abroad was not consid-
ered due to the lack of central recording of these
specific movements. However, it is considered that
the risk posed to the UK from domestic UK animals
becoming infected while abroad would be very low
compared to the risk from animals entering the UK
from abroad. This is because the majority of trips are
likely to be relatively short in duration and most trav-
eling animals would be expected to have only min-
imal contact with the local cat and dog population.
Furthermore, if the animals are fully compliant with
the vaccination requirements, there is a high proba-
bility the animal is protected from clinical infection
even given exposure to the virus.
2.4. Estimation of Risk
For each pet movement policy (quarantine,
PETS, EUPMPunlisted, and EUPMPEU&listed) and
country grouping, the probability of a single pet be-
ing infected and imported (R), which is scenario spe-
cific, was estimated by summing the probabilities
associated with each pathway in the relevant risk
pathway diagram (Figs. 1–3). Consequently, the an-
nual probability of importing at least one infected
cat/dog (PR,j) via a particular scheme for country
group j was estimated by:
PR, j = 1 − (1 − R)NI, j ,
where NI ,j is the number of pets imported via the
particular scheme for country group j; see Table V.
Therefore, the number of years between rabies in-
troductions from a particular group (YR,j) was esti-
mated as:
YR, j = 1PR, j .
The probabilities of at least one infected animal
entering the UK via a particular scheme from either
an EU MS, listed third country, or an unlisted third
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Table VI. Results: Annual Probability of Rabies Introduction to the United Kingdom (PR) via the Pet Travel Scheme (PETS) and the
European Union Pet Movement Policy (EUPMP)
Country Category Scenario Compliance Level 5th Percentile Mean 95th Percentile
EU MSs PETS/Quarantine 100% 3.43 × 10−6 8.34 × 10−6 1.60 × 10−5
EUPMPEU&listed 100% 1.41 × 10−3 2.02 × 10−3 2.79 × 10−3
Listed third countries PETS/Quarantine 100% 1.32 × 10−5 2.64 × 10−5 4.69 × 10−5
EUPMPEU&listed 100% 2.39 × 10−3 2.75 × 10−3 3.15 × 10−3
Unlisted third countries Quarantine 100% 3.91 × 10−5 4.31 × 10−5 4.82 × 10−5
EUPMPunlisted 100% 9.47 × 10−6 2.58 × 10−5 5.05 × 10−5
Overall PETS/Quarantine 100% 5.90 × 10−5 7.79 × 10−5 1.06 × 10−4
PETS/Quarantine 90% 1.12 × 10−3 1.33 × 10−3 1.58 × 10−3
PETS/Quarantine 80% 2.08 × 10−3 2.48 × 10−3 2.97 × 10−3
EUPMP 100% 4.05 × 10−3 4.79 × 10−3 5.65 × 10−3
EUPMP 90% 5.13 × 10−3 5.92 × 10−3 6.85 × 10−3
EUPMP 80% 6.13 × 10−3 6.99 × 10−3 7.99 × 10−3
country were given by:
PR,EU = 1 − (1 − PR,1)(1 − PR,2)(1 − PR,3),
PR,listed = 1 − (1 − PR,4)(1 − PR,5)(1 − PR,6),
PR,unlisted = 1 − (1 − PR,7)(1 − PR,8)(1 − PR,9).
The number of years between introductions from
each country classification is calculated by dividing
1 by these probabilities, that is, 1/PR,EU, 1/PR,listed,
and 1/PR,unlisted. Therefore, the overall annual prob-
ability of at least one infected dog/cat entering the
UK is:
PR = 1 − (1 − PR,EU)(1 − PR,listed)(1 − PR,unlisted),
where the overall number of years between rabies in-
troductions is 1/PR.
2.5. Model Implementation
The model was developed in the software pack-
age @Risk Version 4.5 (C©Palisade), an add-on pack-
age within Microsoft Excel 2003 (C©Microsoft 1985–
2003). Each simulation was run for 50,000 iterations,
which was sufficient to allow convergence of the an-
nual risk of rabies introduction (PR). The results pre-
sented follow the standard form of the arithmetic
mean and the 5th and 95th percentile values.
2.6. Sensitivity and Scenario Analysis
A sensitivity analysis was conducted using the
software in @Risk. The analysis identifies, from those
represented by a distribution, the model parameters
the results are most sensitive to, that is, which in-
puts contribute most to the output uncertainty. In
addition to this analysis, some alternative scenar-
ios are tested to assess how the risk associated with
PETS scheme is affected by the individual require-
ments of the policy. First the consequence of remov-
ing the serological test requirement from PETS is as-
sessed by changing the probability of passing the test
(PST+) to 1. Second, the effect of a reduced waiting
period in PETS is assessed by reducing T in monthly
intervals, from 212 days in the baseline model to 1
day, which is effectively immediate entry (i.e., T =
212, 180, 150 . . .1).
3. RESULTS
The annual probability of rabies introduction to
the UK through PETS /quarantine and EUPMP is
shown in Table VI. Under the current companion an-
imal movement policy of PETS and quarantine, the
annual probability of rabies introduction is 7.79 ×
10−5 (5.90 × 10−5, 1.04 × 10−4), with introduc-
tion from unlisted third countries through quarantine
contributing the highest risk of 4.31 × 10−5 (3.91 ×
10−5, 4.82 × 10−5). This is because the extra elements
of the PETS scheme (on top of the six-month wait)
result in PETS being a “safer” scheme than quaran-
tine alone. Under the EUPMP, the annual probabil-
ity of rabies introduction is predicted to be higher at
4.79 × 10−3 (4.05 × 10−3, 5.65 × 10−3). Interestingly,
the results indicate that companion animal entries
from EU MSs and listed third countries contribute
the most risk under the EUPMP, whereas the risk
of rabies introduction from unlisted third countries is
predicted to decrease compared to PETS/quarantine.
These conclusions are taken from the mean val-
ues. However, when uncertainty is taken into
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Fig. 4. Box plots comparing the annual
risk of rabies introduction to the United
Kingdom (UK) under the current Pet
Travel Scheme (PETS) to the risk of
introduction through the European
Union Pet Movement Policy (EUPMP)
for EU member states (PR,EU), listed
third countries (PR,listed), unlisted third
countries (PR,unlisted), and all regions
combined (PR). Note: All y-axes are the
log10 of the annual probability of rabies
introduction to the UK.
consideration (Fig. 4) there is a much higher amount
of uncertainty associated with the EUPMPunlisted
scheme, with the percentiles fully encompassing the
distribution of results in the quarantine scenarios.
With respect to the number of years between ra-
bies introductions, it is predicted that after a change
in policy to the EUPMP, the overall number of
years between rabies introductions would decrease
from 13,272 (9,408, 16,940) to 211 (177, 247) years
(Table VII).
As expected, when noncompliance is introduced
to the model the risk of rabies introduction to the
UK increases. The effect of this is most notable for
the current scheme of PETS and quarantine, with a
20% reduction in compliance reducing the number of
years between rabies introductions to 408 (337, 482)
years. The effect of noncompliance is less under the
EUPMP, with a decrease in the number of years be-
tween rabies introductions to 144 (125, 163) years if
compliance is reduced by 20%.
A sensitivity analysis indicated that for PETS the
risk of rabies entry is most sensitive to changes in
the sensitivity and the serological test, the efficacy
of the rabies vaccine, and the number of unobserved
Table VII. Results: Expected Number of Years Between Rabies Introduction to the United Kingdom (YR) via Either the Pet Travel
Scheme (PETS) or the European Union Pet Movement Policy (EUPMP)
Country Category Scenario Compliance Level 5th Percentile Mean 95th Percentile
EU MSs PETS/Quarantine 100% 62,683 1,49,129 2,91,248
EUPMPEU&listed 100% 359 517 708
Listed third countries PETS/Quarantine 100% 21,299 43,942 75,973
EUPMPEU&listed 100% 317 366 419
Unlisted third countries Quarantine 100% 20,738 23,302 25,557
EUPMPunlisted 100% 19,792 50,440 1,05,590
Overall PETS/Quarantine 100% 9,408 13,272 16,940
PETS/Quarantine 90% 632 761 894
PETS/Quarantine 80% 337 408 482
EUPMP 100% 177 211 247
EUPMP 90% 146 170 195
EUPMP 80% 125 144 163
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Fig. 5. The change in the probability of rabies introduction to the
United Kingdom (PR) through the Pet Travel Scheme as the total
waiting period is reduced in monthly intervals from 212 days in
the baseline model to a waiting period of 1 day, which is, in effect,
immediate movement of all animals.
infected animals in unlisted countries (λj, j = 7–9).
This result is likely to be because the majority of
the risk associated with this scheme is through un-
detected infected animals entering the UK through
quarantine. Similarly, for EUPMP the vaccine effi-
cacy and the number of unobserved infected animals
from EU MSs and listed third countries (λj, j = 1–6)
contribute the most uncertainty to the overall risk,
again because the majority of the risk associated with
this scheme comes from these country groups.
In a scenario analysis, removing the serologi-
cal test requirement from PETS increases the an-
nual mean risk of rabies introduction approximately
10-fold to 9.17 × 10−4 (5.94 × 10−4, 1.28 × 10−3),
and reduces the number of years between rabies in-
troductions to 1,152 (780, 1682) years. A number of
scenarios were considered where the waiting period
for PETS was reduced in monthly intervals; these
analyses showed that reducing the waiting period in-
creased the risk of rabies introduction, particularly
when the waiting period is less than three months
(Fig. 5).
4. DISCUSSION
The UK has maintained its rabies-free status
since 1922, initially by a six-month quarantine and
since 2000 a combination of PETS and quarantine.
The UK’s derogation from harmonized EU laws
relating to companion animal travel will expire in
December 2011. The QRA presented here was de-
signed to quantify any potential change in risk after
harmonization with EU laws. Assuming that the an-
nual number of companion animal entries is consis-
tent at an average of 46,491, the model results in-
dicate that under the current scheme of PETS and
quarantine there would be, on average, one rabies
introduction every 13,272 years, or one introduction
every 617,028,552 animal entries. Therefore, it can
be concluded that assuming 100% compliance with
the regulations, the risk of rabies introduction to the
UK under the current scheme is very low or negligi-
ble; this is consistent with the fact that the UK has
remained rabies-free in the 10 years since the intro-
duction of PETS. After adoption of the EUPMP, the
mean risk of rabies introduction to the UK is pre-
dicted to increase by approximately 60-fold. It is pre-
dicted that, on average, there will be one rabies in-
troduction every 211 years under the EUPMP, this is
one introduction every 9,806,601 companion animal
entries. Consequently, while an increase in the mean
risk of rabies introduction is predicted after a policy
change to the EUPMP, the absolute risk associated
with both schemes is very low. This risk assessment
differs from previous rabies risk assessments in that
it considers entries to theUK from all countries in the
world, as opposed to entries from only a single coun-
try or region. However, the conclusions from this risk
assessment are consistent with previous assessments
that have suggested that the EUPMP would pose a
higher risk of rabies introduction compared to the
current policy of PETS and quarantine(7) and that the
removal of the serological test requirement from an
entry scheme would increase the likelihood of rabies
introduction,(9) particularly when the waiting period
is also reduced.(31)
When the UK adopts the EUPMP it is predicted
that companion animal entries from listed third coun-
tries would present the highest mean risk of rabies
introduction to the UK, whereas the mean risk of ra-
bies introduction from unlisted third countries would
decrease. These results are supported by the conclu-
sions made in a qualitative risk assessment under-
taken by Defra,(32) which concluded that, under the
EUPMP, there would not be any change to the cur-
rent negligible risk of rabies introduction to the UK
from unlisted third countries, but an increase to a
very low risk of rabies introduction from listed third
countries. The qualitative risk assessment also con-
cluded that there would be no change to the risk
of rabies introduction to the UK from EU MSs un-
der the EUPMP; however, we predict an increase
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to one rabies-infected entry every 517 years (or one
entry every 240,35,847 animals). Although this is al-
most a 300-fold increase in mean risk, the absolute
level of risk could be considered negligible. When
interpreting the results of this risk assessment, un-
certainty must also be taken into consideration. A
large amount of uncertainty is associated with the
predicted risk of rabies introduction from unlisted
third countries under the EUPMP (Fig. 4), the confi-
dence intervals for this result completely encompass
the equivalent results through quarantine. Therefore,
although the mean results suggest a decrease in risk
under the EUPMP, this conclusion is weakened by
the extra uncertainty associated with the EUPMP re-
sults.
One of the main differences between PETS and
the EUPMP is the length of the waiting period. A
scenario analysis showed that reducing the waiting
period of PETS to 90 days did not greatly increase
the mean risk of rabies introduction. However, wait-
ing periods shorter than 90 days resulted in a sub-
stantial increase in risk (Fig. 5). This is an important
result as it suggests that the waiting period change
between the PETS and EUPMPunlisted policies (from
six to three months) would not substantially affect
the mean risk of rabies introduction, but reducing the
waiting period to 21 days (as in EUPMPlisted) would
result in a large increase in risk.
The baseline model for this QRA assumes 100%
compliance, that is, all animals had the correct vacci-
nation and serological test. This approach was taken
as the best available data for compliance indicated
that the current level of compliance with the vacci-
nation and serological test requirements is nearing
100% (only 796 of 191,499 animals (approximately
0.4%) failed to meet the entry requirements for these
reasons between 2005 and 2009).(33) However, the
effect of noncompliance on the risk of rabies intro-
duction to the UK due to companion animal move-
ments has been analyzed by reducing the level of
compliance with the vaccination, serological testing,
and border checking requirements of the schemes.
Previous risk assessments have included noncompli-
ance using uncertainty distributions;(6−8,34) however,
these distributions were not used as they were pub-
lished in 1998 before PETS was introduced, and were
therefore deemed to not accurately represent the
current level of compliance with PETS. Despite this
change in methodology, the results of this QRA are
in agreement with previous studies, indicating that
the risk of rabies introduction to the UK, particu-
larly via PETS, is highly sensitive to noncompliance
with the regulations.(6,7) It is likely that the introduc-
tion of noncompliance to the model has a large ef-
fect due to the assumption of immediate movement
into the UK of animals that were either not vacci-
nated against rabies or serologically tested for rabies
antibodies.
During the development of this risk assessment,
a number of assumptions had to be made either due
to the lack of available data or the uncertainty as-
sociated with the available data. To model the over-
all risk of rabies introduction to the UK in a timely
and efficient manner, the countries of the world were
combined into groups based on their reported num-
ber of rabies cases between 2007 and 2009. The max-
imum number of annual rabies cases in each group
over this period was used in subsequent calculations
to account, to some degree, for underreporting. Fol-
lowing the definition of the groups, where both sets
of quantitative data were available, the data on ra-
bies cases were combined with the companion animal
population for each country. In effect, each group
was treated as one very large country, assuming that
the average rabies prevalence would be representa-
tive of the overall rabies situation in all the coun-
tries in the group and that rabies-infected animals are
homogenously distributed across the countries. Spa-
tial heterogeneity of rabies cases, the quality of each
country’s veterinary surveillance system, and other
factors that could affect the risk of rabies introduc-
tion to the UK could not be considered due to a lack
of specific data in these areas.
The countries of the world were separated into
three groups based on their number of reported ra-
bies cases; where incidence data were not available
a previous HPA rabies risk assessment was used to
assist in categorization.(13) Due to a lack of data on
the pet/wildlife population for each country, and the
likely difference in the owner–animal ratio between
countries, it was not possible to define the country
groupings according to prevalence and incidence was
used as a proxy. After discussion with rabies experts,
a threshold of five cases was selected to differentiate
between Group 2 and 3 countries. As a result of this
some countries with relatively few rabies cases (6–10
between 2007 and 2009) will have been included in
Group 3 along with countries with far greater num-
ber of rabies cases. A full breakdown of results for
the individual country groups (not shown) indicates
that the majority of risk comes from the Group 3
countries. Adjusting the Group 2–Group 3 thresh-
old within a range of reasonable values (5–10 cases)
would be unlikely to significantly affect the results
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and, if anything, the cautionary threshold used in the
model leads to a worse-case scenario.
The proportion of uninfected pets that are pro-
tected from rabies after vaccination was based on
data on the seroconversion of companion animals
above a threshold antibody titer of 0.5 IU/mL, in-
formed by the current EU, WHO, and OIE guide-
lines.(35) However, this is an arbitrary threshold that
is not in accordance with criteria for licensing of vac-
cines for veterinary use, and it has been shown in
some studies that the lack of neutralizing antibod-
ies in vaccinated animals before challenge with ra-
bies virus does not indicate that the animal is unpro-
tected from rabies challenge,(36,37) thus meaning the
value used in the risk assessment may be an under-
estimate, which may lead to an overestimate in the
risk of rabies introduction. A scenario analysis (not
shown) showed that an increase in the probability of
a companion animals being protected after vaccina-
tion would decrease the risk of rabies introduction to
the UK (an increase in vaccine efficacy to 0.9 reduced
the risk associated with PETS/quarantine to 6.52 ×
10−5, or one rabies introduction every 15,496 years).
However, the effect of this change in the parameter
estimate would not affect the overall conclusions of
this QRA or any subsequent policy decisions.
The estimate of the incubation period of rabies
virus used in this QRA was based on data on both
experimentally and naturally infected cases of rabies.
The data were combined due to the high level of
uncertainty associated with both data sets, due to
high infectious doses in experimental cases and un-
certainty about the true incubation period in natu-
rally infected cases, because there was no knowledge
of the true date of infection and the potential for
secondary cases in data on rabies in UK quarantine.
The true incubation period of rabies virus in dogs
and cats, particularly naturally infected cases, is one
of the key data gaps identified by this QRA. Data
that would allow improved estimation of this param-
eter would be advantageous for an improvement to
the estimation of risk in future rabies risk assess-
ments, particularly as one of the important distinc-
tions between the various entry policies is the length
of the waiting period that must be completed before
entry.
There has been a large increase in the number
of companion animals entering the UK in the years
since the introduction of PETS; in 1996, 7,267 cats
and dogs were quarantined in the UK,(8) by 2009
this had increased to 30,268 entries via PETS with a
further 1,099 entries through quarantine (these fig-
ures do not include UK animals returning from trips
abroad). It was assumed that under the EUPMP
there would be no further increase in the number of
companion animal entries to the UK. However, it is
possible that entry numbers would increase after a
change to the EUPMP due to the simplification of
the entry requirements, in which case the risk of ra-
bies introduction to the UK would increase further.
This may be particularly true for entries from un-
listed countries, which would no longer be subject to
the six-month quarantine system.
Finally, it should be noted that this risk assess-
ment only considers the risk of rabies introduction
to the UK via the movement of companion animals.
No consideration was given to other imported dis-
eases/infections that may be associated with dog/cat
travel, in particular leishmaniois and Echinococcus
multilocularis, which have been considered in other
studies.(38,39) On June 30, 2011, the UK government
announced that the UK pet importation policy would
be harmonized with the EU and the EUPMP would
be effective from January 1, 2012;(40) the results of
this risk assessment formed part of the scientific evi-
dence base in this policy decision.
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